Innovative Solutions for Protein Production
Nuclera, a leader in biotechnology, has recently taken a major step forward in streamlining protein production within the drug discovery sector. By installing its cutting-edge eProtein Discovery™ system at Domainex, the first contract research organization (CRO) to adopt this innovative technology, Nuclera is enhancing the landscape of protein research.
Enhancing Drug Discovery at Domainex
Domainex is well-regarded for its comprehensive array of pre-clinical drug discovery services, which range from protein production to medicinal chemistry focused on lead optimization. With the addition of Nuclera’s eProtein Discovery system, Domainex is positioned to significantly enhance its capabilities, making high-quality protein access more efficient for researchers. This collaboration not only expands Domainex's service offerings but also aligns with Nuclera’s mission to promote better human health. By enabling scientists to easily obtain the proteins necessary for drug discovery research, more researchers can benefit.
Speeding Up Protein Expression and Purification
The eProtein Discovery system is designed to accelerate the processes of protein expression and purification in research laboratories, particularly those utilizing artificial intelligence and machine learning. Its capability to employ digital microfluidics, in situ protein detection assays, and cell-free protein synthesis allows for rapid and scalable access to high-quality proteins. As a result, researchers can expect quicker turnaround times and lower costs. This system adeptly automates the various stages of protein production, allowing for purification and functional testing to occur in less than 48 hours, in stark contrast to the months it traditionally takes.
Comments from Company Leaders
Joseph Bertelsen, Chief Commercial Officer at Nuclera, expressed enthusiasm about the partnership, stating: “We are excited to have trusted protein experts like Domainex as our first CRO Partner assisting us in making eProtein Discovery accessible to scientists worldwide. The eProtein Discovery™ system is poised to transform the landscape of protein research, making it an essential tool for anyone involved in the science of proteins.” His comments reflect a strong commitment to facilitating scientists in their pivotal work.
Commitment to Client-Centric Innovation
Natalie Winfield, Executive Vice President of Commercial Operations at Domainex, added her insights into the strategic partnership. “We are delighted to be the first CRO to offer a protein production service via the eProtein Discovery™ system. At Domainex, we are constantly evolving our service offering, ensuring that we have the latest and most innovative technologies,” she noted. This forward-thinking approach underscores Domainex's dedication to offering optimal solutions for drug discovery, ensuring their clients receive the best available services to advance their projects.
Exploring Further Opportunities
Nuclera’s eProtein Discovery system not only supports company initiatives but also serves as a catalyst for enhancing collaborative projects across the industry. Researchers facing challenges in protein production now have an alternative route for accessing innovative technology without the immediate need to invest in the systems themselves. This offers organizations additional flexibility and facilitates a wider range of protein studies.
Frequently Asked Questions
What is the eProtein Discovery system?
The eProtein Discovery system is a benchtop technology developed by Nuclera that accelerates and optimizes protein expression and purification processes.
How does this system benefit researchers?
The system allows researchers to quickly access high-quality proteins for their studies, significantly reducing the time and costs associated with protein production.
What role does Domainex play in this partnership?
Domainex is the first CRO to install the eProtein Discovery system, enhancing their service offerings and enabling clients to benefit from this advanced technology.
Can smaller organizations access the eProtein Discovery system?
Yes, the partnership allows smaller organizations access to the eProtein Discovery technology without requiring them to invest in the system directly.
What is Nuclera’s mission with this technology?
Nuclera aims to promote better human health by facilitating the protein discovery process, making high-quality proteins readily accessible to researchers globally.
